Panacea Biotec Ltd
NSE:PANACEABIO
US |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
|
US |
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
|
US |
Bank of America Corp
NYSE:BAC
|
Banking
|
|
US |
Mastercard Inc
NYSE:MA
|
Technology
|
|
US |
Abbvie Inc
NYSE:ABBV
|
Biotechnology
|
|
US |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
|
US |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
|
US |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
|
US |
Visa Inc
NYSE:V
|
Technology
|
|
CN |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
|
US |
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
|
US |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
|
US |
Coca-Cola Co
NYSE:KO
|
Beverages
|
|
US |
Realty Income Corp
NYSE:O
|
Real Estate
|
|
US |
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
|
US |
Walt Disney Co
NYSE:DIS
|
Media
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
This note will be permanently deleted.
Panacea Biotec Ltd
Operating Income
Panacea Biotec Ltd
Operating Income Peer Comparison
Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors
Company | Operating Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Panacea Biotec Ltd
NSE:PANACEABIO
|
Operating Income
-â‚ą567.7m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
13%
|
CAGR 10-Years
N/A
|
|
Bharat Immunologicals and Biologicals Corporation Ltd
BSE:524663
|
Operating Income
-â‚ą202.8m
|
CAGR 3-Years
-119%
|
CAGR 5-Years
-12%
|
CAGR 10-Years
N/A
|
|
Transgene Biotek Ltd
BSE:526139
|
Operating Income
-â‚ą7.1m
|
CAGR 3-Years
59%
|
CAGR 5-Years
42%
|
CAGR 10-Years
N/A
|
|
Z
|
Zenotech Laboratories Ltd
BSE:532039
|
Operating Income
â‚ą101.4m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
Hester Biosciences Ltd
NSE:HESTERBIO
|
Operating Income
â‚ą364.8m
|
CAGR 3-Years
-13%
|
CAGR 5-Years
-8%
|
CAGR 10-Years
N/A
|
|
Biocon Ltd
NSE:BIOCON
|
Operating Income
â‚ą17.3B
|
CAGR 3-Years
22%
|
CAGR 5-Years
13%
|
CAGR 10-Years
14%
|
See Also
What is Panacea Biotec Ltd's Operating Income?
Operating Income
-567.7m
INR
Based on the financial report for Mar 31, 2024, Panacea Biotec Ltd's Operating Income amounts to -567.7m INR.
What is Panacea Biotec Ltd's Operating Income growth rate?
Operating Income CAGR 5Y
13%
Over the last year, the Operating Income growth was 46%.